Prof. Dr. Torsten Kuwert


Lehrstuhl für Klinische Nuklearmedizin

Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 5 Go to next page Go to last page

Ellmann, S., Seyler, L., Evers, J., Heinen, H., Bozec, A., Prante, O.,... Bäuerle, T. (2019). Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network. Bone, 120, 254-261.
Tatsch, K., Buchert, R., Bartenstein, P., Barthel, H., Boecker, H., Brust, P.,... Meyer, P.T. (2019). SPECT Studies with the I-123-labeled Dopamine Transporter Ligands FP-CIT (DaTSCAN(TM)) DGN Recommendation for Action (S1 Guideline). Nuklearmedizin-Nuclear Medicine, 58(1), 5-14.
Schmidkonz, C., Cordes, M., Schmidt, D., Bäuerle, T., Goetz, T.I., Beck, M.,... Ritt, P. (2018). 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging.
Schmidkonz, C., Hollweg, C., Beck, M., Reinfelder, J., Götz, T., Sanders, J.,... Ritt, P. (2018). 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Prostate, 78(1), 54-63.
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate Cancer. Clinical Nuclear Medicine, 43(8), e250-e258.
Rutzner, S., Lubgan, D., Wullich, B., Kuehn, R., Kuwert, T., & Fietkau, R. (2018). Salvage external beam radiation therapy of biochemical relapse after radical prostatectomy: Results and potential role of PET/CT. (pp. 149-150).
Boy, C., Poeppel, T., Kotzerke, J., Krause, B.J., Amthauer, H., Baum, R.P.,... Bockisch, A. (2018). Somatostatin receptor PET/CT (SSTR-PET/CT). Nuklearmedizin-Nuclear Medicine, 57(1), 4-17.
Schmidkonz, C., Cordes, M., Beck, M., Goetz, T.I., Schmidt, D., Prante, O.,... Ritt, P. (2018). SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer. Clinical Nuclear Medicine.
Cordes, M., Kuwert, T., Haag, C., & Raue, F. (2017). A Novel Mutation of the Calcium Sensing Receptor Gene in a Franconian Kindred: Heterozygous Mutation c.1697_1698delTG Exon 6. Hormone and Metabolic Research, 49(2), 142-146.
Reinfelder, J., Kuwert, T., Beck, M., Sanders, J.C., Ritt, P., Schmidkonz, C.,... Goebell, P. (2017). First Experience With SPECT/CT Using a 99mTc-Labeled Inhibitor for Prostate-Specific Membrane Antigen in Patients With Biochemical Recurrence of Prostate Cancer. Clinical Nuclear Medicine, 42(1), 26-33.

Zuletzt aktualisiert 2016-05-05 um 05:32